Abstract It is well described that patients with pulmonary arteriovenous malformations (PAVMs) and Hereditary Hemorrhagic Telangiectasia (HHT) have an increased risk of cerebral abscess (CA). However, as both CA and HHT are rare, the proportion of patients with CA who are diagnosed with HHT has not been previously described. A retrospective study was carried out of all patients treated surgically for CA between January 1995 and September 2014 at the Department of Neurosurgery, Odense University Hospital. The cases were then cross-referenced with the Danish HHT database. Eighty patients aged 5-79 years were included. The incidence of CA was 0.33/100,000/year. Two patients (2.5%) were registered as having HHT. Bacterial pathogens were identified in 70% of all cases, most frequently streptococci species (46.3%). The most common predisposing condition was odontogenic infection (20%), followed by post-operative infection (13.8%) and post-trauma (6.3%). Patients undergoing a full diagnostic program to determine predisposing conditions causing CA increased over the 20-year period from 11.8% to 65.2%. The 3-month and 1-year mortality rates were 7.5% and 11.25%, respectively. There is an overrepresentation of HHT patients in a cohort of patients with CA, and HHT should be investigated as the cause of the CA if no other apparent cause can be identified.
Introduction
Hereditary hemorrhagic telangiectasia (HHT) is a rare disease also known as Osler-Weber-Rendu disease. It is an autosomal dominant disorder characterized by telangiectatic lesions and arteriovenous malformations (AVMs), resulting in a wide variation of symptoms, among which cerebral abscess (CA) is feared. CA is a rare and severe disease with diffuse symptoms [1, 2] , requiring specialist treatment and neurosurgery in order to reduce morbidity and mortality [3] . Currently, the morbidity and mortality rates are stable at approximately 10-20% [1, 4] . The risk of CA is estimated to be approximately 100 times greater for HHT patients than the general population [5] . Among HHT type 1 patients with pulmonary arteriovenous malformations (PAVMs), the risk is estimated to be 400 times greater [6] . It is the presence of PAVMs in HHT patients (most common in HHT type 1) that is considered to be the main cause of neurological symptoms [5, 7, 8] . PAVMs can cause right to left shunting of blood in the pulmonary circulation, which makes paradoxical embolization possible. This may result in cerebral infarction or a CA [9] . Symptoms of PAVMs may include dyspnea, hemoptysis, cyanosis or chest pain. A smaller proportion of HHT patients may also experience neurological symptoms due to cerebral AVMs [9] .
While bleeding (recurrent epistaxis and gastrointestinal bleeding [9, 10] ) is a very common problem for HHT patients, history regarding these symptoms may easily be overlooked in a patient with CA.
HHT is caused by mutations in three known genes: endoglin (ENG) resulting in HHT type 1; activin A receptor type II-like 1 (ACVRL1) resulting in HHT type 2; and SMAD4 resulting in a syndrome consisting of HHT and juvenile polyposis (JP-HHT) [11] [12] [13] [14] [15] [16] [17] . Approximately 85% of HHT patients have a mutation identified in either the ENG or ACVRL1 genes [17] .
In spite of increased risk of bleeding and embolisms, a recent study concluded that patients with HHT do not have an increased mortality rate compared to the general population [18] .
In the Region of Southern Denmark, HHT has a prevalence of 15.6 per 100,000 and all diagnosed HHT cases are registered in the Danish HHT database [19] . There is only one HHT center in Denmark, to which all Danish HHT patients are referred for genetic counseling and evaluation.
The primary aim of this study was to retrospectively estimate the occurrence of HHT in a cohort of CA patients with bacterial CA treated surgically at Odense University Hospital. The secondary aim was to describe the CA cohort and to evaluate if guidelines for the identification of CA cause were followed.
Materials and methods
All patients admitted to the Department of Neurosurgery at Odense University Hospital between January 1995 and September 2014 with CA were retrospectively identified using medical records. Odense University Hospital provides highlevel care for persons living in the Region of Southern Denmark (population 1.2 million). Cases were identified using codes from the International Classification of Diseases, a modified version of ICD-10, describing both diagnosis and procedures. The code used was BAAM00 -Puncture and evacuation of cerebral abscess^, resulting in 90 cases. All identified records were then manually reviewed and the diagnosis confirmed. Ten patients were excluded since the diagnosis was not confirmed (neoplasia, hematoma, fungal abscesses, or cerebrospinal fluid buildup following shunt dysfunction). The remaining 80 patients were cross-referenced with the Danish HHT database. Further description of the center follows in a separate paragraph.
From the medical records, the following data were collected: medical history, demographics, presence of comorbidities, abscess localization, diagnostic measures, causative microorganisms, and outcome.
A diagnostic program to determine the underlying conditions causing CA was defined as: head computed tomography (CT) and/or magnetic resonance imaging (MRI) scan, echocardiography, oral and maxillofacial surgeon examination, and/or otorhinolaryngologist examination.
Adverse outcome was defined as 3-month and 12-month mortality from the first surgical drainage performed of the CA.
Statistics
The data are presented mainly as descriptive statistics. A p-value <0.05 was considered significant.
Ethics statement
In compliance with Danish law, the study was approved by the Danish Data Protection Agency, and the access to patient clinical records was approved by the Danish National Board of Health. No further ethical approval is needed for registerbased studies in Denmark. Patients were not involved in the design of the study.
HHT database
The national HHT center was established at Odense University Hospital in 1995 on the basis of several years with ongoing epidemiological studies in the County of Fyn, Denmark [20] . The County of Fyn includes 470,000 inhabitants and is part of the Region of Southern Denmark including 1,200,000 inhabitants.
Since 1995, all patients seen at the national HHT center have been clinically evaluated concerning manifestations of HHT and family tracing has been performed intensively, as relatives have been invited and included if they had HHT. All participants have been offered genetic testing. The Danish HHT database was initially based on an epidemiological study performed in the County of Fyn, with a disease prevalence of 15.6 HHT patients per 100,000 in this area. The Danish HHT database has been later expanded to a national database including all HHT patients seen at the national HHT center since 1995. Of these, 181 live in the Region of Southern Denmark, giving the same prevalence of HHT in the entire Region of Southern Denmark as in the County of Fyn. Only patients fulfilling at least three Curacao criteria or having a pathogenic HHT mutation have been included in the Danish HHT database.
Results

Age and demographics
Eighty patients with CA were identified in the study period and, thereby, included in the study. This gave rise to an incidence of 0.33/100,000/year. The median age of the patients was 52 years (range 5-79 years) and 60% were male ( Table 1) .
Position of abscess
The position of the CA was primarily in the frontal lobes (30%), followed by the parietal lobes (23.8%). Location in the cerebellum was the least frequent, reported in only three cases (3.8%). Six cases (7.5%) presented with multiple CA. Information regarding the size of the CA cavity was available in 58 cases, with a median diameter of 40 mm (range 10-100 mm) on the longest side (Table 1) .
Bacteriological findings
Microbiological material was obtained by surgical drainage and sent for microscopy, Gram staining, and culturing in all 80 cases. One or mixed bacterial pathogens were identified in 56 (70%) cases, covering a wide variety of bacteria, as shown in Table 2 . The most common bacterial finding was streptococci species in 37 (46.3%) of all culture-positive cases, with Streptococcus anginosus being the most frequent [23 (28.8%) of the cases], followed by anaerobic bacteria in 18 (22.5%), Gram-negative bacteria in 5 (6.3%), and staphylococci species in 3 (3.8%) cases. Mixed pathogens were present in 14 (17.5%) cases, with up to four different bacterial types. In 24 (30%) cases, no bacterial diagnosis was obtained.
Treatment
Antibiotic therapy was tailored to the causative organism, with metronidazole, penicillin, and ceftriaxone being the most common regime. The length of treatment was between 4 and 12 weeks, consisting of a combination of intravenous and oral treatment. Adjuvant steroid treatment was given in 63.8% of all cases and was defined as doses of methylprednisolone of 80 mg or equivalent to. (Fig. 1) . A predisposing cause for CA was identified as contiguous spread of bacteria in 22 cases (prior neurosurgical procedure: 11 cases, otitis/sinusitis: 6 cases, and penetrating head trauma: 5 cases). Hematogenous spread of the bacteria was identified in 19 cases (dental infection: 16 cases, cardiac condition: 2 cases, and simple skin infection: 1 case). In 39 cases, no predisposing condition was found.
Surgical drainage was performed in all CA cases, either by craniotomy (n = 56; 70%) or burr hole aspiration (n = 24; 30%). In 31 cases (19 craniotomy and 11 burr hole aspiration cases), drainage had to be performed more than once (mean of 1.49 [95% confidence interval (CI): 1.32-1.66] surgical drainages across all 80 cases). There was no significant difference between the choice of drainage method and the need for repeating the procedure (p = 0.327).
HHT
Two patients were found to have HHT:
Patient 1
A 41-year-old male previously diagnosed with HHT. Frequently suffering from dyspnea and bleeding episodes from the oral cavity. He was diagnosed with PAVMs and upper gastrointestinal bleeding. The patient was admitted to a local hospital with monosymptomatic severe headache. Three weeks prior to admission, the patient had a small abscess on the left earlobe. Head CT scan showed signs of a CA in the left temporal lobe. The initial MRI suggested conservative treatment with no surgical drainage to be appropriate (small lesion), but probably due to premature termination of antibiotics, headache returned, together with nausea and vomiting. A new MRI showed a 3-cm abscess formation. Surgical drainage through a burr hole was performed. A culture from the extracted pus was negative. The patient was treated with intravenous antibiotics and recovered without sequelae. One year later, the patient was treated for his PAVMs with embolization therapy.
Patient 2
A 46-year-old male previously diagnosed with HHT was admitted with headache, left-sided hemiparesis, and partial loss of vision. His symptom from HHT was repeatedly heavy epistaxis. Head CT showed a 4-cm CA in the left occipital lobe and a craniotomy was performed, evacuating the pus. A culture from the extracted pus was negative. The patient was treated with ampicillin, gentamicin, and metronidazole, and transferred to a local hospital with impaired vision as sequelae. Examination performed by an oral and maxillofacial surgeon revealed severe periodontal disease and several teeth were removed. An otorhinolaryngology examination and echocardiography was also performed, without additional findings.
Nine years later, the patient suffered a cerebral infarction in the occipital lobe, resulting in complete loss of vision, and two years later, the patient was examined for PAVMs with a CT scan. This revealed two large PAVMs. The patient was offered embolization therapy, but declined.
In both HHT patients, the diagnosis was confirmed with mutation analysis, and both had HHT type 1.
The estimated prevalence of HHT is 15.6/100,000 [2] . As patients with verified HHT accounted for 2 out of the 80 patients, this translates into an estimated relative risk of 164.7 (95% CI 40.77-665.43, p < 0.0001) for a patient with HHT to encounter a CA compared to the background population.
Patient outcome
The 3-month and 1-year mortality rates were 7.5% and 11.3%, respectively.
Discussion
The purpose of this study was to estimate the occurrence of HHT among patients with bacterial CA. We found two HHT patients (both having PAVMs) in the CA cohort of 80 patients, although small numbers we believe that HHT and PAVM should be considered as the causes of CA. Further, with precaution due to the small numbers, we found a significantly elevated risk of 164.7 of HHT patients having CA compared to the background population. Even though there could be an underestimation of HHT patients in the CA cohort combined with the fact that we deal with very small numbers, it is still our assessment that the data from the Region of Southern Denmark is a unique opportunity to carry out these calculations, as this is one of the most complete known records of HHT patients identified (181 cases in 1,200,000). As the national HHT center is a tertiary center, a selection bias could be an issue; however, in the hospital uptake area, we have performed family tracing during the last 30 years of research and, therefore, we believe that the majority of HHT patients independent of disease severity have been identified. This, together with CA data for the neurosurgery department covering the exact same region, offers this possibility. Another study based on data from the Danish HHT -database showed the prevalence of CA in HHT patients to be 2.6%; however, among HHT patients with PAVMs it was 7.8% [5] . In an Italian and a French study, prevalence was calculated to be 5% and 4.8%, respectively, for all HHT patients [6, 21] . For only patients with PAVMs, the prevalence was 10% in the Italian study [21] . This correlates well with the findings in this study that both HHT patients identified with CA had PAVMs. Only CA patients undergoing neurosurgical procedures as part of their treatment were included in this study. A study by Helweg-Larsen et al. found an overall incidence of CA of 0.4/ 100,000/year and that 89% of all CA were treated surgically [1] . The same (88.9%) was been found to apply for HHT patients treated for CA [22] . A Finnish study concluded that the incidence of surgically treated CA was 0.33/100,000/year [23] . This is the same as the calculated incidence of 0.33/ 100,000/year for CA in this study.
The data indicate that the majority of HHT patients diagnosed with a CA had no prior knowledge of them suffering from HHT [5, 21] , and that the treating doctors are unaware of the relation between HHT, PAVMs, and CA and, therefore, fail to diagnose HHT/ PAVMs [5] . This was also the case in patient no. 2, where the PAVMs were first identified nine years after the CA diagnosis. Screening the medical history for symptoms of PAVMs and HHT should, therefore, be performed in all patients having CA not directly related to trauma or neurosurgery. This includes a history focusing on previous epistaxis, gastrointestinal bleeding, and neurological disease, and if there is any familial occurrence of HHT or CA. If a patient is suspected to have HHT, referral to an HHT center is advised, where genetic testing, counseling, and mutation diagnostics is offered. All patients with suspected or known HHT should be screened for PAVMs. This includes contrast echocardiography and, if positive, a subsequent CT of the chest [24] . If a PAVM with feeding arteries larger than 2 mm is identified, the patient should be offered embolization therapy [24] . We advocate that patients with CA are screened for the presence of PAVM, although this has not previously been the routine in our hospital.
The distribution of pathogens found matches those of similar studies, with the majority of CA containing bacteria of the streptococci family, with S. anginosus being the most prevalent [1, 22, 23] . Mathis et al. previously found that HHT patients with CA often had >1 bacterial isolate compared to non-HHT patients [22] . We were unable to confirm this in our study, as the two HHT patients both returned culture negative. Negative culture results are not just a problem in HHT patients, as 30% of all cultures were negative, a diagnostic challenge seen throughout the literature on CA [6, 19, 22] . This may possibly be the result of antibiotic treatment prior to surgery.
The CA was, in 16 (20%) cases, caused by poor dental status, making this the largest known focus in this study. CA of oral origin is a known complication of poor oral conditions, but is often presented on a case-to-case basis in journals [25] . In Denmark, dental care is free for persons under the age of 18 years, and is then partially subsidized according to the socio-economic state. There are, in other words, good possibilities of maintaining a good oral condition, compared to most countries.
Data gathered regarding outcome, although rather crude due to poor follow-up, yielded a 3-month mortality of 7.5% and a 12-month mortality of 11.25%. The results from similar studies report a mortality ranging from 9% to 19%, ranking mortality in the present study among the more favorable [4, 22] . There was only complete follow-up for the patients that died in close relation to neurosurgery.
Conclusion
Hereditary hemorrhagic telangiectasia (HHT) patients have a severely increased risk of developing a cerebral abscess (CA) compared to the general population. HHT patients should be screened for pulmonary arteriovenous malformations (PAVMs) and general awareness of PAVMs is needed. Clinicians dealing with CA patients should consider PAVMs/HHT as an underlying cause of right to left shunt and paradoxical emboli, and include contrast echocardiography in the primary screening of patients with CA, especially if hematogenous spread is suspected as the cause of CA.
